An exciting Project-ALS funded study on the involvement of the gene TDP-43 in ALS-frontotemporal dementia. Understanding how TDP-43 contributes to neurodegeneration will help direct therapeutic efforts. Read here

BREAKING NEWS
Dear Friends, BREAKING NEWS: The all-new drug developed by the Project ALS Therapeutics Core for the treatment of ALS, is now moving into Phase 1